ProShares Ultra CRCL
CRCA
6 hedge funds and large institutions have $1.09M invested in ProShares Ultra CRCL in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
54% more call options, than puts
Call options by funds: $1.38M | Put options by funds: $895K
0.14% more ownership
Funds ownership: 0% → 0.14% (+0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Belvedere Trading
Chicago,
Illinois
|
+$322K |
| 2 |
JF
Jump Financial
Chicago,
Illinois
|
+$289K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$175K |
| 4 |
Barclays
London,
United Kingdom
|
+$161K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$141K |
Top Sellers
CRCA Hedge Fund Activity: Q3 2025 in Review
6 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra CRCL (CRCA) for Q3 2025, worth a combined $1.09M.
Buyers outnumbered sellers: 6 funds opened new CRCA positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Belvedere Trading, opening a new position worth an estimated $322K.
- 6 institutional investors held ProShares Ultra CRCL (CRCA) as of Q3 2025, up from 0 in Q2 2025.
- Funds reported $1.09M of ProShares Ultra CRCL stock for Q3 2025.
- 6 funds opened new ProShares Ultra CRCL positions in Q3 2025 and 0 closed out, a net change of +6 holders.
- The largest ProShares Ultra CRCL buyer in Q3 2025 was Belvedere Trading, an estimated $322K added.
Based on aggregated 13F filings for Q3 2025.